North America Chronic Cough Market Key Companies and SWOT Analysis by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, and Other Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Country

Report Date : Aug 2020
Report Code : TIPRE00013291

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 97

Page Updated: Jan 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Chronic Cough market in North America is expected to grow from US$ 2,118.42 million in 2019 to US$ 3,944.89 million by 2027. This represents a CAGR of 8.1% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the North American chronic cough market during the forecast period.

The US has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in North America during the forecast period. Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others. Additionally, , the government initiatives for the treatment, diagnosis and awareness program will further propel the growth in the country. For instance, The Temple Lung Center’s Chronic Cough Program team specializes in finding the cause of your chronic cough and can offer treatments to lessen the cough or address the underlying medical condition. In addition, The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with health care professionals and public health officials around the world to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease.

US Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA CHRONIC COUGH – MARKET SEGMENTATION

By Drug Class

Antihistamines
Corticosteroids
Decongestants
Combination Drug
Antibiotics
Acid Blockers
Other Drug Class

By Route of Administration

Oral
Injections
Nasal
Other Route of Administration

By Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

By Country

US
Canada
Mexico

Company Profiles

Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline plc.
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group plc.
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd

North America Chronic Cough Report Scope

Report Attribute	Details
Market size in 2019	US$ 2,118.42 Million
Market Size by 2027	US$ 3,944.89 Million
Global CAGR (2020 - 2027)	8.1%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Drug Class Antihistamines Corticosteroids Decongestants Combination Drug Antibiotics Acid Blockers Other Drug Class By Route of Administration Oral Injections Inhalation Other Route of Administration By Distribution Channel Hospital Pharmacy Online Pharmacy Retail Pharmacy
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Novartis AG Teva Pharmaceutical Industries Ltd GlaxoSmithKline plc. Bayer AG Mylan N.V. Amneal Pharmaceuticals, Inc. Cipla Inc. Reckitt Benckiser Group plc. Sun Pharmaceutical Industries Ltd

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Chronic Cough Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy